Drug Developer Plans To Proceed With Late-Stage Trial Of COVID-19 Drug After FDA Declines Authorization

Reuters (3/14, Satija) reports that on Tuesday, Veru Inc “said it plans to proceed with a late-stage trial of its COVID-19 pill, weeks after the” FDA “declined to authorize the oral drug to treat high-risk patients hospitalized with COVID-19.” The company...